HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of remifentanil with dexmedetomidine for monitored anaesthesia care in elderly patients during vertebroplasty and kyphoplasty.

AbstractOBJECTIVES:
This clinical trial is registered at ClinicalTrials.gov. (NCT02476981)This randomized, prospective double-blind study compared remifentanil with dexmedetomidine for monitored anaesthesia care during minimally invasive corrections of vertebral compression fractures (vertebroplasty or kyphoplasty).
METHODS:
Patients > 65 years of age with American Society of Anesthesiologists (ASA) classification I-III, scheduled for vertebroplasty or kyphoplasty under monitored anaesthesia care, received remifentanil (i.v. infusion 1-5 µg/kg/h) or dexmedetomidine (loading dose 0.3-0.4 µg/kg followed by i.v. infusion 0.2-1 µg/kg/h) to maintain observer's assessment of alertness/sedation (OAA/S) scale <4 during the procedure.
RESULTS:
There were no statistically significant differences in demographic data between the remifentanil (n = 37) and dexmedetomidine groups (n = 38). Patients on dexmedetomidine experienced lower mean arterial pressure (MAP) and heart rate (HR), and higher SpO2 values, than patients on remifentanil. Compared with dexmedetomidine, remifentanil produced more respiratory depression, oxygen desaturation, and reduced the need for additional intraoperative opioids. There were no significant between-group differences in terms of recovery time, investigators' satisfaction scores, or patients' overall pain experiences.
CONCLUSIONS:
During monitored anaesthesia care, dexmedetomidine provides less respiratory depression, lower MAP and HR, but also less analgesic effect than remifentanil in elderly patients undergoing vertebroplasty or kyphoplasty.
AuthorsJung Min Lee, Soo Kyung Lee, Sang Jun Lee, Woon Suk Hwang, Sung Wook Jang, Eun Young Park
JournalThe Journal of international medical research (J Int Med Res) Vol. 44 Issue 2 Pg. 307-16 (Apr 2016) ISSN: 1473-2300 [Electronic] England
PMID26912506 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Copyright© The Author(s) 2016.
Chemical References
  • Analgesics, Non-Narcotic
  • Anesthetics, Intravenous
  • Piperidines
  • Dexmedetomidine
  • Remifentanil
Topics
  • Aged
  • Aged, 80 and over
  • Analgesics, Non-Narcotic (therapeutic use)
  • Anesthetics, Intravenous (therapeutic use)
  • Blood Pressure (drug effects)
  • Conscious Sedation (methods)
  • Dexmedetomidine (therapeutic use)
  • Double-Blind Method
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Kyphoplasty
  • Male
  • Middle Aged
  • Piperidines (therapeutic use)
  • Prospective Studies
  • Remifentanil

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: